Subscribe To Our Free Newsletter |
Aurobindo Pharma jumps on USFDA nod for Fingolimod capsules
Aurobindo Pharma rallied 4.83% to Rs 1,076.10 after the drug maker received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fingolimod capsules.